Clinical Trials List
2025-03-07 - 2032-02-28
Phase III
Recruiting3
ICD-10E85.0
Non-neuropathic heredofamilial amyloidosis
ICD-10E85.1
Neuropathic heredofamilial amyloidosis
ICD-10E85.2
Heredofamilial amyloidosis, unspecified
ICD-10E85.3
Secondary systemic amyloidosis
ICD-10E85.4
Organ-limited amyloidosis
ICD-10E85.8
Other amyloidosis
ICD-10E85.9
Amyloidosis, unspecified
ICD-9277.3
Amyloidosis
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- YEN-HUNG LIN Division of General Internal Medicine
- MEI-FANG CHENG Division of Nuclear Medicine
- JYH-MING JIMMY JUANG Division of General Internal Medicine
- HSUEH-WEN HSUEH Division of Neurology
- 黃昱森 Division of Radiology
- SUNG-TSANG HSIEH Division of Neurology
- Ming-Jen Lee Division of Neurology
- 謝榮賢 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chung Yu Division of Cardiovascular Diseases
- 邱睿涵 Division of Radiology
- 蕭丞宗 Division of Neurology
- 胡蓮欣 Division of Nuclear Medicine
- 季康揚 Division of Neurology
- 張富邦 Division of Others
- Kon-Ping Lin Division of Neurology
- Yi-Chu Liao Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
582 participants
